Skip to main content

Craniopharyngioma

  • Living reference work entry
  • First Online:
Book cover Textbook of Pediatric Neurosurgery

Abstract

The term craniopharyngioma was coined 85 years ago by Frazier and Alpers and initially described by Cushing as a “baffling problem.” This problem although better understood remains baffling. The optimal treatment which will provide good quality longevity to these children remains to be fully defined. A multimodality approach determined by the age of the patient, the cystic or solid nature of the tumor, and the size of the tumor at presentation is necessary in the armamentarium of the practitioner treating patients with this tumor. We review the epidemiology, the clinical presentation, and the treatment modalities for both cystic and solid tumors with their complications and efficacies in this chapter. Emerging therapeutic approaches based on molecular studies and strategies targeting specific pathways offer promise that the armamentarium available to treat this tumor in young children will broaden in years to come.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Abedalthagafi M, Bi WL, Aizer AA, Merrill PH, Brewster R, Agarwalla PK, Listewnik ML et al (2016) Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro-Oncology 18(5):649–655

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Albright AL, Hadjipanayis CG, Lunsford LD, Kondziolka D, Pollack IF, Adelson PD (2005) Individualized treatment of pediatric craniopharyngiomas. Childs Nerv Syst 21(8–9):649–654

    Article  PubMed  Google Scholar 

  • Ali ZS, Bailey RL, Daniels LB, Vakhshori V, Lewis DJ, Hossain AT, Sitterley KY et al (2014) Comparative effectiveness of treatment options for pediatric craniopharyngiomas. J Neurosurg Pediatr 13(2):178–188

    Article  PubMed  Google Scholar 

  • Andoniadou CL, Gaston-Massuet C, Reddy R, Schneider RP, Blasco MA, Le Tissier P, Jacques TS, Pevny LH, Dattani MT, Martinez-Barbera JP (2012) Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma. Acta Neuropathol 124(2):259–271

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Andoniadou CL, Matsushima D, Mousavy Gharavy SN, Signore M, Mackintosh AI, Schaeffer M, Gaston-Massuet C, et al (2013) Sox2 stem/progenitor cells in the adult mouse pituitary support organ homeostasis and have tumor-inducing potential. Cell Stem Cell. https://doi.org/10.1016/j.stem.2013.07.004

    Article  CAS  PubMed  Google Scholar 

  • Apps JR, Carreno G, Gonzalez-Meljem JM, Haston S, Guiho R, Cooper JE, Manshaei S et al (2018) Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target. Acta Neuropathol 135(5):757–777

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Backlund EO (1973) Studies on craniopharyngiomas. 3. Stereotaxic treatment with Intracystic Yttrium-90. Acta Chir Scand 139(3):237–247

    CAS  PubMed  Google Scholar 

  • Bartels U, Laperriere N, Bouffet E, Drake J (2012) Intracystic therapies for cystic craniopharyngioma in childhood. Front Endocrinol. https://doi.org/10.3389/fendo.2012.00039

  • Belen D, Er U, Yigitkanli K, Bolay H (2007) Delayed neurotoxic complication of intracavitary bleomycin therapy for craniopharyngioma in a child who had previously undergone radiosurgery. Case report. J Neurosurg 106(5 Suppl):391–393

    PubMed  Google Scholar 

  • Blackburn TP, Doughty D, Plowman PN (1999) Stereotactic intracavitary therapy of recurrent cystic craniopharyngioma by instillation of 90yttrium. Br J Neurosurg 13(4):359–365

    Article  CAS  PubMed  Google Scholar 

  • Brastianos PK, Santagata S (2016) ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma. Eur J Endocrinol/European Federation of Endocrine Societies 174(4):R139–R144

    Article  CAS  Google Scholar 

  • Brastianos PK, Horowitz PM, Santagata S, Jones RT, McKenna A, Getz G, Ligon KL et al (2013) Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet 45(3):285–289

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Buslei R, Nolde M, Hofmann B, Meissner S, Eyupoglu IY, Siebzehnrübl F, Hahnen E, Kreutzer J, Fahlbusch R (2005) Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the Sellar region. Acta Neuropathol 109(6):589–597

    Article  CAS  PubMed  Google Scholar 

  • Buslei R, Hölsken A, Hofmann B, Kreutzer J, Siebzehnrubl F, Hans V, Oppel F, Buchfelder M, Fahlbusch R, Blümcke I (2007) Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas. Acta Neuropathol 113(5):585–590

    Article  CAS  PubMed  Google Scholar 

  • Buslei R, Rushing EJ, Giangaspero F, Paulus W (2016) Craniopharyngioma. WHO classification of

    Google Scholar 

  • Campanini ML, Colli LM, Paixao BMC, Cabral TPF, Amaral FC, Machado HR, Neder LS et al (2010) CTNNB1 gene mutations, pituitary transcription factors, and microRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas. Hormones Cancer 1(4):187–196

    Article  CAS  PubMed  Google Scholar 

  • Cani CMG, Matushita H, Carvalho LRS, Soares IC, Brito LP, Almeida MQ, Mendonça BB (2011) PROP1 and CTNNB1 expression in adamantinomatous craniopharyngiomas with or without β-catenin mutations. Clinics 66(11):1849–1854

    PubMed  PubMed Central  Google Scholar 

  • Cao J, Lin JP, Yang LX, Chen K, Huang ZS (2010) Expression of aberrant β-catenin and impaired p63 in craniopharyngiomas. Br J Neurosurg. https://doi.org/10.3109/02688690903576237

    Article  Google Scholar 

  • Carreno G, Boult JKR, Apps JR, Gonzalez-Meljem JM, Haston S, Guiho R, Stache C, et al (2019) SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma. Endocr Relat Cancer. https://doi.org/10.1530/ERC-18-0538

  • Cavalheiro S, Dastoli PA, Silva NS, Toledo S, Lederman H, da Silva MC (2005) Use of interferon alpha in intratumoral chemotherapy for cystic craniopharyngioma. Childs Nerv Syst 21(8–9):719–724

    Article  CAS  PubMed  Google Scholar 

  • Cavalheiro S, Di Rocco C, Valenzuela S, Dastoli PA, Tamburrini G, Massimi L, Nicacio JM et al (2010) Craniopharyngiomas: intratumoral chemotherapy with interferon-α: a multicenter preliminary study with 60 cases. Neurosurg Focus 28(4):E12

    Article  PubMed  Google Scholar 

  • Chakrabarti I, Amar AP, Couldwell W, Weiss MH (2005) Long-term neurological, visual, and endocrine outcomes following transnasal resection of craniopharyngioma. J Neurosurg 102(4):650–657

    Article  PubMed  Google Scholar 

  • Clark VE, Zeynep Erson-Omay E, Serin A, Yin J, Cotney J, Ozduman K, Avşar T et al (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339(6123):1077–1080

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Coy S, Rashid R, Lin J-R, Ziming D, Donson AM, Hankinson TC, Foreman NK et al (2018) Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma. Neuro-Oncology 20(8):1101–1112

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cushing H (1932) Intracranial tumours. J Nerv Ment Dis. https://doi.org/10.1097/00005053-193211000-00086

    Article  Google Scholar 

  • Derrey S, Blond S, Reyns N, Touzet G, Carpentier P, Gauthier H, Dhellemmes P (2008) MANAGEMENT OF CYSTIC CRANIOPHARYNGIOMAS WITH STEREOTACTIC ENDOCAVITARY IRRADIATION USING COLLOIDAL 186. Neurosurgery. https://doi.org/10.1227/01.neu.0000335786.10968.2f

    Article  PubMed  Google Scholar 

  • Desai SS, Paulino AC, Mai WY, Teh BS (2006) Radiation-induced moyamoya syndrome. Int J Radiat Oncol Biol Phys 65(4):1222–1227

    Article  PubMed  Google Scholar 

  • Donson AM, Apps J, Griesinger AM, Amani V, Witt DA, Anderson RCE, Niazi TN, et al (2017) Molecular analyses reveal inflammatory mediators in the solid component and cyst fluid of human adamantinomatous craniopharyngioma. J Neuropathol Exp Neurol. https://doi.org/10.1093/jnen/nlx061

    Article  CAS  Google Scholar 

  • Elliott RE, Hsieh K, Hochm T, Belitskaya-Levy I, Wisoff J, Wisoff JH (2010) Efficacy and safety of radical resection of primary and recurrent craniopharyngiomas in 86 children. J Neurosurg Pediatr. https://doi.org/10.3171/2009.7.peds09215

    PubMed  Google Scholar 

  • Elliott RE, Jane JA Jr, Wisoff JH (2011) Surgical management of craniopharyngiomas in children: meta-analysis and comparison of transcranial and transsphenoidal approaches. Neurosurgery 69(3):630–643; discussion 643

    Article  PubMed  Google Scholar 

  • Erdheim J (1904) About hypophyseal adenomas and brain craniopharyngiomas. Akad Wiss Wien 113:537–726

    Google Scholar 

  • Esheba GE, Hassan AA (2015) Comparative immunohistochemical expression of β-catenin, EGFR, ErbB2, and p63 in adamantinomatous and papillary craniopharyngiomas. J Egypt Natl Canc Inst 27(3):139–145

    Article  PubMed  Google Scholar 

  • Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M (1999) Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 90(2):237–250

    Article  CAS  PubMed  Google Scholar 

  • Frazier CH, Alpers BJ (1934) TUMORS OF RATHKE’S CLEFT: (HITHERTO CALLED TUMORS OF RATHKE'S POUCH). Arch Neurol Psychiatr 32(5):973–984

    Article  Google Scholar 

  • Friedman DP, Gandhe AR (2015) Chapter 3 – imaging of craniopharyngiomas and radiologic differential diagnosis. In: Kenning TJ, Evans JJ (eds) Craniopharyngiomas. Academic Press, Boston, pp 59–94

    Chapter  Google Scholar 

  • Gomes DC, Jamra SA, Leal LF, Colli LM, Campanini ML, Oliveira RS, Martinelli CE Jr et al (2015) Sonic hedgehog pathway is upregulated in adamantinomatous craniopharyngiomas. Eur J Endocrinol/European Federation of Endocrine Societies 172(5):603–608

    Article  CAS  Google Scholar 

  • Greenfield BJ, Okcu MF, Baxter PA, Chintagumpala M, Teh BS, Dauser RC, Jack S, Desai SS, Paulino AC (2015) Long-term disease control and toxicity outcomes following surgery and Intensity Modulated Radiation Therapy (IMRT) in pediatric craniopharyngioma. Radiother Oncol 114(2):224–229

    Article  PubMed  Google Scholar 

  • Gump JM, Donson AM, Birks DK, Amani VM, Rao KK, Griesinger AM, Kleinschmidt-DeMasters BK et al (2015) Identification of targets for rational pharmacological therapy in childhood craniopharyngioma. Acta Neuropathol Commun 3(May):30

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hader WJ, Steinbok P, Hukin J, Fryer C (2000) Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children. Pediatr Neurosurg 33(4):211–218

    Article  CAS  PubMed  Google Scholar 

  • Haisa T, Ueki K, Yoshida S (1994) Toxic effects of bleomycin on the hypothalamus following its administration into a cystic craniopharyngioma. Br J Neurosurg. https://doi.org/10.3109/02688699409101192

    Article  CAS  PubMed  Google Scholar 

  • Hasegawa T, Kondziolka D, Hadjipanayis CG, Dade Lunsford L (2004) Management of cystic craniopharyngiomas with Phosphorus-32 intracavitary irradiation. Neurosurgery 54(4):813–820; discussion 820–22

    Article  PubMed  Google Scholar 

  • Hechtman CD, Li Z, Mansur DB, Perez CA, Myerson RJ, Simpson JR, Anders JC, Wu C, Palucci CA (2005) Dose distribution outside of a sphere of P-32 chromic phosphorous colloid. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/j.ijrobp.2004.12.071

    Article  CAS  Google Scholar 

  • Hölsken A, Buchfelder M, Fahlbusch R, Blümcke I, Buslei R (2010) Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling. Acta Neuropathol 119(5):631–639

    Article  CAS  PubMed  Google Scholar 

  • Hölsken A, Stache C, Schlaffer SM, Flitsch J, Fahlbusch R, Buchfelder M, Buslei R (2014) Adamantinomatous craniopharyngiomas express tumor stem cell markers in cells with activated Wnt signaling: further evidence for the existence of a tumor stem cell niche? Pituitary 17(6):546–556

    Article  CAS  PubMed  Google Scholar 

  • Hölsken A, Sill M, Merkle J, Schweizer L, Buchfelder M, Flitsch J, Fahlbusch R et al (2016) Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles. Acta Neuropathol Commun 4(February):20

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Honegger J, Buchfelder M, Fahlbusch R (1999) Surgical treatment of craniopharyngiomas: endocrinological results. J Neurosurg 90(2):251–257

    Article  CAS  PubMed  Google Scholar 

  • Hukin J, Steinbok P, Lafay-Cousin L, Hendson G, Strother D, Mercier C, Samson Y, Howes W, Bouffet E (2007) Intracystic bleomycin therapy for craniopharyngioma in children: the Canadian experience. Cancer 109(10):2124–2131

    Article  CAS  PubMed  Google Scholar 

  • Ierardi DF, Fernandes MJS, Silva IR, Thomazini-Gouveia J, Silva NS, Dastoli P, Toledo SRC, Cavalheiro S (2007) Apoptosis in alpha interferon (IFN-α) intratumoral chemotherapy for cystic craniopharyngiomas. Childs Nerv Syst 23(9):1041–1046

    Article  CAS  PubMed  Google Scholar 

  • Jakacki RI, Cohen BH, Jamison C, Mathews VP, Arenson E, Longee DC, Hilden J et al (2000) Phase II evaluation of interferon α-2a for progressive or recurrent craniopharyngiomas. J Neurosurg 92(2):255–260

    Article  CAS  PubMed  Google Scholar 

  • Julow J, Lányi F, Hajda M, Szeifert GT, Viola A, Bálint K, Nyáry I (2007) Stereotactic intracavitary irradiation of cystic craniopharyngiomas with Yttrium-90 isotope. Prog Neurol Surg 20:289–296

    Article  PubMed  Google Scholar 

  • Kalapurakal JA, Stewart G, Hsieh YC, Tomita T, Marymont MH (2003) Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse. Med Pediatr Oncol 40(4):214–218

    Article  PubMed  Google Scholar 

  • Karavitaki N, Brufani C, Warner JT, Adams CBT, Richards P, Ansorge O, Shine B, Turner HE, Wass JAH (2005) Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol 62(4):397–409

    Article  CAS  Google Scholar 

  • Kato K, Nakatani Y, Kanno H, Inayama Y, Ijiri R, Nagahara N, Miyake T et al (2004) Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol 203(3):814–821

    Article  CAS  PubMed  Google Scholar 

  • Katoh Y, Katoh M (2009) Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr Mol Med 9(7):873–886

    Article  CAS  PubMed  Google Scholar 

  • Kilday JP, Caldarelli M, Massimi L, Chen RH, Lee YY, Liang ML, Parkes J, Naiker T, van Veelen ML, Michiels E, Mallucci C, Pettorini B, Meijer L, Dorfer C, Czech T, Diezi M, Schouten-van Meeteren AYN, Holm S, Gustavsson B, Benesch M, Müller HL, Hoffmann A, Rutkowski S, Flitsch J, Escherich G, Grotzer M, Spoudeas HA, Azquikina K, Capra M, Jiménez-Guerra R, MacDonald P, Johnston DL, Dvir R, Constantini S, Kuo MF, Yang SH, Bartels U (2017) Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN. Neuro Oncol 19(10):1398–1407. https://doi.org/10.1093/neuonc/nox056. PubMed PMID: 28499018; PubMed Central PMCID: PMC5596165

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim S-D, Park J-Y, Park J, Lee J-B, Kim S-H, Lim D-J (2007) Radiological findings following postsurgical intratumoral bleomycin injection for cystic craniopharyngioma. Clin Neurol Neurosurg 109(3):236–241

    Article  PubMed  Google Scholar 

  • Komotar RJ, Starke RM, Raper DMS, Anand VK, Schwartz TH (2012) Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of giant pituitary adenomas. Pituitary 15(2):150–159

    Article  PubMed  Google Scholar 

  • Kramer S, Mckissock W, Concannon JP (1961) Craniopharyngiomas. Treatment by combined surgery and radiation therapy. J Neurosurg 18(March):217–226

    Article  CAS  PubMed  Google Scholar 

  • Kuan EC, Kaufman AC, Lerner D, Kohanski MA, Tong CCL, Tajudeen BA, Parasher AK, et al (2019) Lack of sphenoid pneumatization does not affect endoscopic endonasal pediatric skull base surgery outcomes. Laryngoscope. https://doi.org/10.1002/lary.27600

    Article  PubMed  Google Scholar 

  • Kubo O, Takakura K, Miki Y, Okino T, Kitamura K (1974) Intracystic therapy of bleomycin for craniopharyngioma--effect of bleomycin for cultured craniopharyngioma cells and intracystic concentration of bleomycin (author’s transl). No shinkei geka. Neurol Surg 2(10):683–88

    Google Scholar 

  • Lafay-Cousin L, Bartels U, Raybaud C, Kulkarni AV, Guger S, Huang A, Bouffet E (2007) Neuroradiological findings of bleomycin leakage in cystic craniopharyngioma. Report of three cases. J Neurosurg 107(4 Suppl):318–323

    Article  PubMed  Google Scholar 

  • Larkin SJ, Ansorge O (2013) Pathology and pathogenesis of craniopharyngiomas. Pituitary 16(1):9–17

    Article  PubMed  Google Scholar 

  • Maciel-Barón LA, Morales-Rosales SL, Aquino-Cruz AA, Triana-Martínez F, Galván-Arzate S, Luna-López A, González-Puertos VY, López-Díazguerrero NE, Torres C, Königsberg M (2016) Senescence associated secretory phenotype profile from primary lung mice fibroblasts depends on the senescence induction stimuli. Age 38(1):26

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Madsen PJ, Buch VP, Douglas JE, Parasher AK, Lerner DK, Alexander E, Workman AD, et al (2019) Endoscopic endonasal resection versus open surgery for pediatric craniopharyngioma: comparison of outcomes and complications. J Neurosurg Pediatr, June, 1–10

    Google Scholar 

  • Martinez-Barbera JP, Andoniadou CL (2016) Concise review: paracrine role of stem cells in pituitary tumors: a focus on adamantinomatous craniopharyngioma. Stem Cells 34(2):268–76. https://doi.org/10.1002/stem.2267. Epub 2016 Jan 13. Review. PubMed PMID: 26763580; PubMed Central PMCID: PMC4864894

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Merchant TE, Kun LE, Hua CH, Wu S, Xiong X, Sanford RA, Boop FA (2013) Disease control after reduced volume conformal and intensity modulated radiation therapy for childhood craniopharyngioma. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/j.ijrobp.2012.10.030

    Article  Google Scholar 

  • Mottolese C, Stan H, Hermier M, Berlier P, Convert J, Frappaz D, Lapras C (2001) Intracystic chemotherapy with bleomycin in the treatment of craniopharyngiomas. Childs Nerv Syst. https://doi.org/10.1007/s00381-001-0524-5

    Article  CAS  PubMed  Google Scholar 

  • Mottolese C, Szathmari A, Berlier P, Hermier M (2005) Craniopharyngiomas: our experience in Lyon. Childs Nerv Syst 21(8–9):790–798

    Article  CAS  PubMed  Google Scholar 

  • Müller HL (2017) Diagnosis, treatment, clinical course, and prognosis of childhood-onset craniopharyngioma patients. Minerva Endocrinol 42(4):356–375

    PubMed  Google Scholar 

  • Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro-Oncology. https://doi.org/10.1093/neuonc/noy131

    Article  PubMed  Google Scholar 

  • Parasher AK, Lerner DK, Glicksman JT, Storm PB, Lee JYK, Vossough A, Brooks S, Palmer JN, Adappa ND (2019) The impact of expanded endonasal skull base surgery on midfacial growth in pediatric patients. Laryngoscope. https://doi.org/10.1002/lary.28063

  • Park DH, Park JY, Kim JH, Chung YG, Lee HK, Lee KC, Suh JK (2002) Outcome of postoperative intratumoral bleomycin injection for cystic craniopharyngioma. J Korean Med Sci 17(2):254–259

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pascual JM, Prieto R, Carrasco R, Barrios L (2013) Displacement of mammillary bodies by craniopharyngiomas involving the third ventricle: surgical-MRI correlation and use in topographical diagnosis. J Neurosurg 119(2):381–405

    Article  PubMed  Google Scholar 

  • Pereira AM, Schmid EM, Schutte PJ, Voormolen JHC, Biermasz NR, van Thiel SW, Corssmit EPM, Smit JWA, Roelfsema F, and Romijn JA (2005) High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin Endocrinol. https://doi.org/10.1111/j.1365-2265.2004.02196.x

    Article  PubMed  Google Scholar 

  • Pollock BE, Lunsford LD, Kondziolka D, Levine G, Flickinger JC (1995) Phosphorus-32 intracavitary irradiation of cystic craniopharyngiomas: current technique and long-term results. Int J Radiat Oncol Biol Phys 33(2):437–446

    Article  CAS  PubMed  Google Scholar 

  • Prieto R, Pascual JM, Rosdolsky M, Castro-Dufourny I, Carrasco R, Strauss S, Barrios L (2016) Craniopharyngioma adherence: a comprehensive topographical categorization and outcome-related risk stratification model based on the methodical examination of 500 tumors. Neurosurg Focus 41(6):E13

    Article  PubMed  Google Scholar 

  • Prieto R, Pascual JM, Barrios L (2017) Topographic diagnosis of craniopharyngiomas: the accuracy of MRI findings observed on conventional T1 and T2 images. Am J Neuroradiol. https://doi.org/10.3174/ajnr.a5361

    Article  CAS  PubMed  Google Scholar 

  • Puget S, Garnett M, Wray A, Grill J, Habrand J-L, Bodaert N, Zerah M et al (2007) Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg 106(1 Suppl):3–12

    PubMed  Google Scholar 

  • Rajan B, Ashley S, Thomas DGT, Marsh H, Britton J, Brada M (1997) Craniopharyngioma: improving outcome by early recognition and treatment of acute complications. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/s0360-3016(96)00537-8

    Article  CAS  Google Scholar 

  • Sadeghi M, Moradi S, Shahzadi S, Pourbeigi H (2007) Dosimetry of 32P radiocolloid for treatment of cystic craniopharyngioma. Appl Radiat Isot. https://doi.org/10.1016/j.apradiso.2007.01.018

    Article  CAS  PubMed  Google Scholar 

  • Savas A, Erdem A, Tun K, Kanpolat Y (2000) Fatal toxic effect of bleomycin on brain tissue after intracystic chemotherapy for a craniopharyngioma: case report. Neurosurgery 46(1):213–216; discussion 216–17

    Article  CAS  PubMed  Google Scholar 

  • Schoenfeld A, Pekmezci M, Barnes MJ, Tihan T, Gupta N, Lamborn KR, Banerjee A, et al (2012) The superiority of conservative resection and adjuvant radiation for craniopharyngiomas. J Neuro-Oncol. https://doi.org/10.1007/s11060-012-0806-7

    Article  PubMed  Google Scholar 

  • Signore M, Jayakody SA (2011) Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans. Proc. https://www.pnas.org/content/108/28/11482.short

  • Stripp DCH, Maity A, Janss AJ, Belasco JB, Tochner ZA, Goldwein JW, Moshang T, et al (2004) Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/s0360-3016(03)01570-0

    Article  Google Scholar 

  • Takahashi H, Nakazawa S, Shimura T (1985) Evaluation of postoperative intratumoral injection of bleomycin for craniopharyngioma in children. J Neurosurg. https://doi.org/10.3171/jns.1985.62.1.0120

    Article  CAS  PubMed  Google Scholar 

  • Takahashi H, Yamaguchi F, Teramoto A (2005) Long-term outcome and reconsideration of intracystic chemotherapy with bleomycin for craniopharyngioma in children. Childs Nerv Syst 21(8–9):701–704

    Article  PubMed  Google Scholar 

  • Taylor MD, Northcott PA, Korshunov A, Remke M, Cho Y-J, Clifford SC, Eberhart CG et al (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 123(4):465–472

    Article  CAS  Google Scholar 

  • Voges J, Sturm V, Lehrke R, Treuer H, Gauss C, Berthold F (1997) Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources. Neurosurgery 40(2):263–269; discussion 269–70

    Article  CAS  PubMed  Google Scholar 

  • Yamada S, Fukuhara N, Oyama K, Takeshita A, Takeuchi Y, Ito J, Inoshita N (2010) Surgical outcome in 90 patients with craniopharyngioma: an evaluation of transsphenoidal surgery. World Neurosurg 74(2–3):320–330

    Article  PubMed  Google Scholar 

  • Yamada S, Fukuhara N, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Inoshita N, Ito J (2018) Therapeutic outcomes of transsphenoidal surgery in pediatric patients with craniopharyngiomas: a single-center study. J Neurosurg Pediatr 21(6):549–562

    Article  PubMed  Google Scholar 

  • Yang S-H, Kim IS, Hong JT, Sung JH, Son BC, Lee SW (2009) Intratumoral bleomycin injection as a primary therapy for cystic craniopharyngioma. Neuro-Oncol 11:903–903. OXFORD UNIV PRESS INC JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA

    Google Scholar 

  • Zuhur SS, Tanik C, Erol RS, Musluman AM, Kabukcuoglu F, Altuntas Y (2012) Immunohistochemical expression of ErbB2 in adamantinomatous craniopharyngiomas: a possible target for immunotherapy. Turk Neurosurg. https://doi.org/10.5137/1019-5149.jtn.6706-12.1

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean-Pierre Farmer .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Farmer, JP., Hankinson, T., Dudley, R. (2019). Craniopharyngioma. In: Di Rocco, C., Pang, D., Rutka, J. (eds) Textbook of Pediatric Neurosurgery. Springer, Cham. https://doi.org/10.1007/978-3-319-31512-6_87-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31512-6_87-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-31512-6

  • Online ISBN: 978-3-319-31512-6

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics